News [Publication Type]
Recent news on Biopharma Sentiment Index (BPSI)
Biopharma Sentiment Index; BPSI; Endpoints News; biopharma sentiment survey; drug development sentiment; biotech investing sentiment; pharma industry outlook
Eli Lilly Signs Up to $2.6 Billion Deal with South Korean Biotech for RNA Medicine Delivery
Eli Lilly; SanegeneBio; South Korean biotech; RNAi medicines; metabolic diseases; LEAD platform; strategic partnership; cardiometabolic; deal value; pharma news
AnaptysBio Halts Phase 2 Ulcerative Colitis Trial; Lyell Immunopharma Secures CAR-T Rights
AnaptysBio; rosnilimab; ulcerative colitis; Phase 2 trial; clinical failure; trial discontinuation; Lyell Immunopharma; CAR-T therapy; licensing deal; biotech news; rheumatoid arthritis
Recent News: Live at 11 a.m. ET – M&A, FDA, MFN and Collaboration with FT
M&A; FDA; MFN; Financial Times; mergers and acquisitions; drug approval; economics; live news
No Recent News Specifically About ‘Click here to continue reading’
click here to continue reading; news; recent news; web navigation; internet phrase
Endpoints News Launches Industry Sentiment Survey, But No Evidence Yet of a New Biopharma Sentiment Index
Endpoints News; biopharma; sentiment; survey; industry trends; John Carroll
LEO Pharma Acquires Exclusive Global Rights for Boehringer Ingelheim’s Psoriasis Drug Spevigo in €90 Million Deal
LEO Pharma; Boehringer Ingelheim; Spevigo; spesolimab; psoriasis; GPP; drug licensing; immunology; IL-36 receptor; partnership; biotech news
Sernova Chair Resigns After Insider Trading Indictment Tied to Novartis-Chinook Deal
Sernova Biotherapeutics; insider trading; resignation; Ross Haghighat; Novartis-Chinook acquisition; securities fraud; biotech news; DOJ indictment
Incyte’s $750M Acquisition Hits Roadblock: Key Trial Paused and Asset Cull Announced
Incyte, $750M buyout, paused trial, asset cull, biotech news, pharmaceutical industry
Takeda Terminates Partnership with Wave Life Sciences on Huntington’s Disease Program
Takeda, Wave Life Sciences, Huntington’s disease, WVE-003, partnership termination, biotech news